Find Drug Substances that produce:
Intermediates
Filters
Production region
Production scale
Qualifications
Follow us
CDMO-CRO
Plants in:
Established in: 1886
Production scale:
medium
small
Employees: 275+
Raw materials, CMO and OTC products
Two GMP certified locations
Customisable (small-sized) packages
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2008
Production scale:
large
small
medium
Employees: 4.000
With 14 production sites in Europe and the USA
7 Development Centers of Excellence covering all dosage forms
13 locations with Technology Services on site for seamless Tech Transfer and product Life-Cycle Management
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2012
Production scale:
medium
Employees: 180
A high-tech enterprise with 13 own patents granted
Strong R&D system with ISO9001 / ISO14001 / OHSAS18001 certification
Provide professional CMO & CDMO service
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2013
Production scale:
medium
Employees: 25+
ISO9001 certified
Drug R&D center (in Hangzhou)
From lab scale (mg/g) to commercial scale (kgs/tons)
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2006
Production scale:
small
medium
Employees: 20
Quality Assurance: Products are manufactured from the finest raw materials and undergo rigorous testing.
Tailored Customisation & Compliance: Providing end-to-end solutions to meet your business
Dependable Expertise and Supply: Backed by years of industry experience and a robust supply chain.
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1952
Production scale:
small
medium
large
Employees: 550+
API manufacturing (Innovators, Generics and Highly Potent)
A tailor-made and flexible service approach
State-of-the-art analytical services including solid form and QbD laboratories
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2006
Production scale:
small
medium
large
Employees: 3500
Silver EcoVadis awardee committed to sustainability
Exceptional synthesis experience of HPAPIs
One-stop CDMO Solutions for APl and Key intermediates
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1965
Production scale:
small
medium
large
Employees: 600+
Pharmaceutical-quality dextrans meeting the highest standards and complying with major pharmacopeias
Manufactured in a cGMP facility in Denmark, inspected by both the FDA and EMA
Documented quality and certifications from the US FDA and EDQM for smooth regulatory submission
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1989
Production scale:
large
Employees: 5000+
6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO
R&D Centers with capabilities of ANDAs, DMFs and NDDS
462+ patents filed for drug substances and polymorphs
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1993
Production scale:
small
medium
large
Employees: 600
Integrated innovative platforms for Technology Transfer (TT&GO®)
Fermentation, purification, and chemical synthesis technologies on the same site
Scalability from Laboratory and Pilot to Industrial scales
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2003
Production scale:
large
Employees: 4000+
20+ years’ expertise in API manufacturing, trusted for quality and global compliance.
Listed pharma leader in China, prioritizing transparency and regulatory excellence.
End-to-end integration from R&D to scalable production, delivering cost-efficient solutions.
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1987
Production scale:
medium
small
large
Employees: 50+
ISO 9001:2015 & SGS audited supplier
One-stop CDMO Solutions for APl and Key intermediates
Specialized in APIs & Pharmaceutical Intermediates for 38 years
All certificates
Replies quickly
Plants in:
Established in: 2008
Production scale:
large
medium
Employees: 300+
More than 150 patents based on independent intelligence
Expertise in anti-tumor, anti-diabetes and cardiovascular API and intermediates.
GMP facility with annual production capacity of 300M
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2021
Production scale:
small
Employees: 19
API, Intermediates, Building Blocks, Impurities, Amino acids and Peptides
Small quantity APIs to commercial scale
GMP and USFDA certification based on quantity, order, assignment.
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1951
Production scale:
medium
Employees: 455+
Largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market.
FDA approved european manufcaturing facilities
Export APIs to more than 60 countries worldwide
All certificates
Replies quickly
Plants in:
Established in: 2014
Production scale:
small
medium
large
Employees: 1000+
23 years of production experience
6 workshops and 9 production lines which has 100t/month production capacity
4 USDMFS & 5 CEPS & 200+ Patents
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1964
Production scale:
small
medium
large
Employees: 135+
Market leader in Switzerland
Small and medium batch sizes
Pharmaceutical raw materials with a herbal or synthetic basis
All certificates
Replies quickly
Plants in:
Established in: 1982
Production scale:
small
Employees: 30+
Modern GMP facility
Team of academics and technical experts
Small to large batch sizes possible
All certificates
Replies quickly
Looking for Drug Substance Services?
Find a list of providers specializing in CMOs/CDMOs Services for Intermediates. Navigate through our extensive selection to identify the supplier that aligns with your specific needs.
Pharmaoffer makes it easy and convenient to send inquiries at no cost. Directly connect with your chosen supplier and take the first step towards fulfilling your pharmaceutical needs easily and efficiently.
Drug Substance (CDMO/CRO)
Drug Substance CDMOs and CROs provide end-to-end solutions for pharmaceutical companies developing and manufacturing active pharmaceutical ingredients (APIs). These organizations offer critical support in R&D, process development, scale-up, and GMP manufacturing, enabling pharma and biotech companies to accelerate time-to-market while ensuring compliance with global regulatory standards.
Intermediates
Pharmaceutical intermediates are key components in the synthesis of APIs. CDMOs offer scalable production and regulatory-compliant services to support drug manufacturing pipelines.
